Comparison

Eupatorin European Partner

Item no. TMO-T7032-20mg
Manufacturer TargetMol
CASRN 855-96-9
Amount 20 mg
Quantity options 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 20 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,9809
Formula C18H16O7
Smiles COc1ccc(cc1O)-c1cc(=O)c2c(O)c(OC)c(OC)cc2o1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias ,P450
Shipping Condition Cool pack
Available
Manufacturer - Targets
Cytochromes P450
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
344.32
Description
Eupatorin has antiproliferative and antiangiogenic effects. Eupatorin has antiproliferative and cytostatic effects on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism. Eupatorin-induced cell death is mediated by both the extrinsic and the intrinsic apoptotic pathways and through a mechanism dependent on reactive oxygen species generation. Eupatorin also has meaningful anti-inflammatory property.
Pathways
Metabolism
Bioactivity
Eupatorin has antiproliferative and antiangiogenic effects. Eupatorin has antiproliferative and cytostatic effects on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism. Eupatorin-induced cell death is mediated by both the extrinsic and the intrinsic apoptotic pathways and through a mechanism dependent on reactive oxygen species generation. Eupatorin also has meaningful anti-inflammatory property.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 20 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close